BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17390069)

  • 1. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
    Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
    Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of DNA mismatch repair protein hMSH2 immunohistochemistry with p53 and apoptosis in cervical carcinoma.
    Köster F; Schröer A; Fischer D; Greweldinger T; Diedrich K; Friedrich M
    Anticancer Res; 2007; 27(1A):63-8. PubMed ID: 17352217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases.
    Larsen NB; Heiberg Engel PJ; Rasmussen M; Rasmussen LJ
    APMIS; 2009 Nov; 117(11):839-48. PubMed ID: 19845535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor and Patient Characteristics of Individuals with Mismatch Repair Deficient Colorectal Cancer.
    Waldmann E; Ferlitsch M; Binder N; Sellner F; Karner J; Heinisch B; Klimpfinger M; Trauner M
    Digestion; 2015; 91(4):286-93. PubMed ID: 25924923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
    Backes FJ; Leon ME; Ivanov I; Suarez A; Frankel WL; Hampel H; Fowler JM; Copeland LJ; O'Malley DM; Cohn DE
    Gynecol Oncol; 2009 Sep; 114(3):486-90. PubMed ID: 19515405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA mismatch repair protein expression and microsatellite instability in primary mucosal melanomas of the head and neck.
    Marani C; Alvino E; Caporali S; Vigili MG; Mancini G; Rahimi S
    Histopathology; 2007 May; 50(6):780-8. PubMed ID: 17493242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!
    Fadhil W; Field J; Cross G; Kaye P; Ilyas M
    Histopathology; 2012 Sep; 61(3):522-5. PubMed ID: 22642480
    [No Abstract]   [Full Text] [Related]  

  • 9. MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.
    Nelson GS; Pink A; Lee S; Han G; Morris D; Ogilvie T; Duggan MA; Köbel M
    Gynecol Oncol; 2013 Nov; 131(2):309-14. PubMed ID: 23938375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan.
    Chen JR; Chiang JM; Changchien CR; Chen JS; Tang RP; Wang JY
    Br J Surg; 2008 Jan; 95(1):102-10. PubMed ID: 18064717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
    Balogh GA; Russo IH; Russo J
    Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.
    Ruiz I; Martín-Arruti M; Lopez-Lopez E; Garcia-Orad A
    Gynecol Oncol; 2014 Jul; 134(1):20-3. PubMed ID: 24814467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer.
    Murata H; Khattar NH; Gu L; Li GM
    Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
    Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
    Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
    Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
    Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome.
    Barrow E; Jagger E; Brierley J; Wallace A; Evans G; Hill J; McMahon R
    Histopathology; 2010 Feb; 56(3):331-44. PubMed ID: 20459533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
    Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
    Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.